Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, double-blind, placebo-controlled trial evaluating Bifidobacterium breve + Bifidobacterium longum + Fructooligosaccharides (FOS) + Lacticaseibacillus casei + Lacticaseibacillus rhamnosus + Lactobacillus acidophilus + Lactobacillus delbrueckii bulgaricus + Streptococcus thermophilus in 40 enrolled asthmatic patients.
Outcome measures:
Pulmonary function tests, Interleukin-4 (IL-4) and Interferon Type II (IFN Type II) / Interferon Gamma (IFN-g) levels, and expression of microRNAs were assessed at baseline and after treatment.
Conc…